Total syntheses of (.+-.)-duanomycinone. Regiospecific preparations of (.+-.)-7,9-dideoxydaunomycinone and 6,11-dihydroxy-4-methoxy-7,8,9,10-tetrahydronaphthacene-5,9,12-trione
Total syntheses of (.+-.)-duanomycinone. Regiospecific preparations of (.+-.)-7,9-dideoxydaunomycinone and 6,11-dihydroxy-4-methoxy-7,8,9,10-tetrahydronaphthacene-5,9,12-trione
E-SELECTIN ANTAGONIST COMPOUNDS AND METHODS OF USE
申请人:GLYCOMIMETICS, INC.
公开号:US20150284420A1
公开(公告)日:2015-10-08
Provided herein are E-selectin antagonist therapeutic agents and improvements thereto and compositions comprising these E-selectin antagonists. Methods are also provided for using these E-selectin antagonist therapeutic agents to treat and/or prevent diseases and disorders treatable by inhibiting binding of an E-selectin to an E-selectin ligand. Also provided herein improvements to E-selectin antagonist glycomimetic compounds that improve the oral bioavailability of the glycomimetic compounds.
Total syntheses of (.+-.)-duanomycinone. Regiospecific preparations of (.+-.)-7,9-dideoxydaunomycinone and 6,11-dihydroxy-4-methoxy-7,8,9,10-tetrahydronaphthacene-5,9,12-trione